Eduardo Alvarez Acquires 11,834 Shares of Amyris Inc (AMRS) Stock

Amyris Inc (NASDAQ:AMRS) COO Eduardo Alvarez bought 11,834 shares of the stock in a transaction on Thursday, December 13th. The stock was purchased at an average price of $4.23 per share, with a total value of $50,057.82. Following the completion of the acquisition, the chief operating officer now directly owns 333,876 shares in the company, valued at approximately $1,412,295.48. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of AMRS stock traded down $0.12 during mid-day trading on Friday, hitting $4.09. The stock had a trading volume of 1,075,233 shares, compared to its average volume of 1,499,206. Amyris Inc has a 12-month low of $3.19 and a 12-month high of $9.28.

Amyris (NASDAQ:AMRS) last issued its quarterly earnings data on Tuesday, November 13th. The biotechnology company reported ($1.13) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.96). The company had revenue of $14.90 million during the quarter, compared to analysts’ expectations of $46.72 million. Amyris’s revenue was down 38.4% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.81) EPS. As a group, equities analysts forecast that Amyris Inc will post -1.34 EPS for the current year.

Several equities research analysts have weighed in on the company. HC Wainwright set a $15.00 target price on Amyris and gave the stock a “buy” rating in a report on Thursday, October 4th. Zacks Investment Research cut Amyris from a “hold” rating to a “sell” rating in a report on Tuesday, October 9th. BidaskClub cut Amyris from a “sell” rating to a “strong sell” rating in a report on Tuesday, November 20th. Finally, B. Riley set a $10.00 target price on Amyris and gave the stock a “buy” rating in a report on Monday, September 17th. One analyst has rated the stock with a sell rating, one has given a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $8.83.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Fox Run Management L.L.C. purchased a new stake in shares of Amyris during the 3rd quarter worth $121,000. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Amyris during the 3rd quarter worth $127,000. Rhumbline Advisers purchased a new stake in shares of Amyris during the 2nd quarter worth $147,000. B. Riley Wealth Management Inc. purchased a new stake in shares of Amyris during the 3rd quarter worth $159,000. Finally, Renaissance Technologies LLC purchased a new stake in shares of Amyris during the 2nd quarter worth $167,000. Hedge funds and other institutional investors own 32.21% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Eduardo Alvarez Acquires 11,834 Shares of Amyris Inc (AMRS) Stock” was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.com-unik.info/2018/12/16/eduardo-alvarez-acquires-11834-shares-of-amyris-inc-amrs-stock.html.

About Amyris

Amyris, Inc, an integrated renewable products company, engages in the research, development, and production of ingredients for the health and wellness, clean beauty, and flavors and fragrances markets worldwide. It applies its bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products.

Featured Story: Google Finance Portfolio Workaround

Insider Buying and Selling by Quarter for Amyris (NASDAQ:AMRS)

Receive News & Ratings for Amyris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amyris and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit